Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Biocidal product factsheet - Last updated: 19/06/2024
Biocidal product factsheet
Trade name:
Neutralac® Calci-flo Optilight
Neutralac® Q
Neutralac® Q1
Neutralac® Q2
Neutralac® Q2 DB
Neutralac® Q200
Neutralac® Q3
Neutralac® Q3-7
Neutralac® Q90
Neutralac® Q90 SR
Product-type:
PT02
Substance name:
IUPAC name:
oxocalcium
EC number:
215-138-9
CAS number:
1305-78-8
BAS number:
1259
Authorisation type:
Union authorisation
Opinions:
Assessment reports:
Authorisation number | SPC | Decisions | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Neutralac® Calci-flo Optilight Neutralac® Q Neutralac® Q1 Neutralac® Q2 Neutralac® Q2 DB Neutralac® Q200 Neutralac® Q3 Neutralac® Q3-7 Neutralac® Q90 Neutralac® Q90 SR |
PT02
|
Austria Belgium Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Latvia Lithuania Luxembourg Malta Netherlands Poland Portugal Romania Slovakia Slovenia Spain Sweden |
Lhoist | EU-0029494-0000 | EU-0029494-0000 | 19/06/2024 | 30/11/2033 |
|
Authorised |
Authorisation number: EU-0029494-0000| Market area: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
1 assessment record available
Evaluating authority:
ECHA
Conclusion date:
31/05/2024
Start date:
19/06/2024
End date:
30/11/2033